Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calmodulin-like protein 6 (CALML6) is a member of the calmodulin family of calcium-binding proteins, characterized by EF-hand motifs that mediate calcium ion binding[1][2][6]. CALML6 is thought to play a role in intracellular calcium signaling pathways, which regulate diverse cellular processes such as muscle contraction, cell growth, immune responses, and potentially neurological functions[1][2]. It is expressed in a range of tissues, including brain, muscle, and immune cells, and is located in both the cytoplasm and nucleus[1][2][4][6]. While altered expression of CALML6 has been associated with certain types of cancer, neurological disorders, and infection responses[1][2], its precise physiological and pathological roles remain incompletely defined and are currently under investigation. No drugs are known to target this protein directly, and it is not an established therapeutic target based on current data[1][2][6].
Not applicable (no known drugs/interactions)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calmodulin-like protein 6 (CALML6).